博士后合作导师

邹如海

主任医师

研究方向：肿瘤超声介入、肿瘤超声诊断及影像组学、分子影像学。

医疗、科研工作总结：

胜任肝胆外科、超声科的各项超声介入工作。超声介入工作量多年全科排名第一（2007~2014年及2015~2017年），年均798例（科平均624例/年）。擅长难度大的超声介入操作，约210例/年。无发生医疗差错或事故，无医疗投诉。

院内术中超声的主要承担者之一，进行术中超声探查及肿瘤消融；在此基础上开展术中超声造影探查结直肠癌肝转移（CLMs）微小病灶及消失病灶，早期复发率（25%）低于文献报道（58%+），为CLMs达到无疾病状态提供重要支持和保障。目前，我院CLMs 5年RFS 35.4%，5年OS 43.2%，国内领先，与国际水平一致。翻译及出版了国内第一及目前唯一的术中超声论著《超声引导下肝脏外科手术图解》。

参与友科项目实验设计，独立完成大肝癌粗针活检1200+例，并发症小于2%，低于文献报道，产出Jama Oncology1篇（IF 24.799，共一）及申请专利1项。临床及研究方向：超声介入及术中超声、分子影像学、人工智能辅助超声诊断。

（以第一/共一作者或通讯/共同通讯作者）发表论文:

1.Hu T, Li Z, Peng C, Huang L, Li H, Han X, Long X, Huang W, Zou R. Nomogram to differentiate benign and malignant thyroid nodules in the American College of Radiology Thyroid Imaging Reporting and Data System level 5. Clin Endocrinol (Oxf). 2023 Feb;98(2):249-258. doi: 10.1111/cen.14824. Epub 2022 Oct 3. PMID: 36138550. IF 3.523

2.Zhong Liu, Shaobin Zhong, Qiang Liu, Chenxi Xie, Yunzhu Dai, Chuan Peng, Xin Chen* & Ruhai Zou*. Thyroid nodule recognition using a joint convolutional neural network with information fusion of ultrasound images and radiofrequency data. Eur Radiol. 2021 Jul;31(7):5001-5011. IF 7.034

3.Yunzhu Dai, Yuanping Zhang, Wei He, Chuan Peng, Jiliang Qiu, Nan Zheng, Huifang Li, Wenwu Liu, Yun Zheng, Binkui Li, Yunfei Yuan & Ruhai Zou *. Long-term outcome for colorectal liver metastases: combining hepatectomy with intraoperative ultrasound guided open microwave ablation versus hepatectomy alone. International Journal of Hyperthermia. 2021, 38(1), 372–381. IF 3.753

4.HuiFang Li, Can Huang, Qiuyan Chen, Chuan Peng, Rong Zhang, Jingxian Shen, Mingyuan Chen, Haiqiang Mai, Ruhai Zou. Lymph‑node Epstein–Barr virus concentration in diagnosing cervical lymph‑node metastasis in nasopharyngeal carcinoma. European Archives of Oto-Rhino-Laryngology. 2020;277:2513–2520. IF 3.236

5.He M, Li Q (Co-first), Zou R (Co-first), Shen J (Co-first), Fang W, Tan G, Zhou Y, Wu X, Xu L, Wei W, Le Y, Zhou Z, Zhao M, Guo Y, Guo R, Chen M, Shi M. Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion: A Randomized Clinical Trial. JAMA Oncol. 2019;5(7):953-960. IF 33.006

6.Yang Z, Zou R (Co-first), Zheng Y, Qiu J, Shen J, Liao Y, Zhang Y, Wang C, Wang Y, Yuan Y, Li K, Zuo D, He W, Liu W, Li B, Yuan Y. Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation. Eur Radiol. 2019 Apr 16. 7.034

7.Ruyuan Song, Chuan Peng, Xiaonan Xu, Ruhai Zou*, Yanxia Shi*. Facile fabrication of uniform nanoscale perfluorocarbon droplets as ultrasound contrast agents. Microfluidics and Nanofluidics (2019) 23:12. IF 3.09